# Long-term Durability Study of Collagenase Clostridium Histolyticum (CCH)

> **NCT04381117** · — · COMPLETED · sponsor: **Endo Pharmaceuticals** · enrollment: 7 (actual)

## Conditions studied

- Edematous Fibrosclerotic Panniculopathy

## Interventions

- **DRUG:** Previously Treated with EN3835

## Key facts

- **NCT ID:** NCT04381117
- **Lead sponsor:** Endo Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-06
- **Primary completion:** 2020-06-22
- **Final completion:** 2020-06-22
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2024-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04381117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04381117, "Long-term Durability Study of Collagenase Clostridium Histolyticum (CCH)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04381117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*